RxDoctor Payments Data

Vivian Bishay, MD

Vascular & Interventional Radiology · New York, NYNPI 1245526433

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (55.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Penumbra, Inc. at 56.9% of the total. 2025 is the largest year on record at $46,977, more than ten times the $1,313 reported in 2019. Among vascular & interventional radiology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$103,568in general payments, 2019–2025

Across 150 payments — averaging $690.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$59K
  • Boston Scientific$26K
  • Inari Medical, Inc.$7K
  • Imperative Care, Inc$6K
  • Cook Incorporated$3K
  • Biocompatibles, Inc.$949
  • plus $1K from 13 others
$205,894in research payments, 2019–2025

Across 59 payments — averaging $3489.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Penumbra, Inc.$123K
  • Boston Scientific$83K
$15,885in ownership & investment interests, 2019–2025

Across 1 payment — averaging $15,885 each. An ownership or investment interest held by the physician or an immediate family member.

  • Thrombolex, Inc.$16K

What the payments were for

  • Consulting fees$24,15723%
  • Speaking & faculty fees$57,12555%
  • Travel & lodging$15,27915%
  • Food & beverage$7,0087%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$103,568 in reported general payments places this provider in the 90th percentile of 306 vascular & interventional radiology providers in New York.

See all vascular & interventional radiology providers in New York

Medicare billing

Part B allowed, 2024
$105,973
Medicare patients
271
Services billed
7,006

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →